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ABSTRACT 
Nanoemulsion has been identified as a promising delivery system for various drugs including Biopharmaceuticals. Nanoemulsion is 
heterogeneous system composed of one immiscible liquid dispersed as droplets within another liquid. Aim of the present study was to 
investigate the nanoemulgel as transdermal delivery system for poorly water soluble drug, Tolnaftate in order to overcome the troubles 
associated with its oral delivery. Different nanoemulsion components (Oil, Surfactant and Cosurfactant) were selected on the basis of solubility 
and emulsification ability. High pressure Homogenization techninique were used for the preparation of Nanoemulsion. Carbopol 934 was added 
as gel matrix to convert nanoemulsion into nanoemulgel. Drug loaded Nanoemulgels were characterized for particle size, SEM, Viscosity, 
Spreadability, Diffusion study using egg membrane, Nanoemulgel containing 3 % Almond oil, 5.25 % Tween 80, Proplene glycol as Cosurfactant, 
1 % drug, Water upto Quantity sufficient was concluded as optimized formulation (F1).  
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INTRODUCTION 
Common known skin fungal infections are caused by yeasts 
such as Candida and the disease name is Candidiasis or 
dermatophytes, such as Epidermophyton, Microsporum and 
Trichophyton (like Dermatophytoses, Ringworm, Tinea). 
Many of these fungi live only in the stratum corneum which 
is topmost layer of the epidermis. and do not penetrate 
deeper. These eruptions like dermatophytids are allergic 
reactions to the fungus. Fungal diseases are commonly 
caused by fungi that are present in the environment 
commonly. Most fungi are not dangerous, but some can be 
harmful to health. Mild fungal skin diseases symptoms can 
look like a rash and are very common. Fungus diseases of 
lungs are commonly similar to flu or tuberculosis like illness. 
Certain fungal diseases like bloodstream infections and 
fungal meningitis are less common than skin and lung 
infections but can be lethal. 
There are various conventional routes of drug 
administration system namely oral, sublingual, rectal, 
parenteral etc. for the treatment of different kinds of 
disorders. Topical drug delivery system is generally used for 
to cure the skin infection like fungal infection. Topical drug 
delivery system can be defined as localized drug delivery 
system where drug incorporated into medication to the skin 
to get localizing effect of drug cure skin disorder. Topical 
drug delivery system have been used for treatment of both 
dermatological and cosmetic to their disease or healthy skin. 
Avoidance of the risks and inconveniences of intravenous 
therapy and of the varied conditions of absorption like pH 
changes, presence of enzymes, gastric emptying time are 
advantages of topical preparations. Topically applied dermal 
or transdermal delivery systems could replace needles 
required to administer many of the new biologics-based 
drugs and vaccines, in addition to other significant 
advantages such as avoiding first pass hepatic metabolism, 
gastric degradation and frequent dosing. However, the 
limited dermal and transdermal delivery of many small and 
large molecules is a significant challenge because of the 
unyielding barrier properties of the skin. A nanoemulsion 
can be categorized into oil-in-water (o/w) nanoemulsion and 
water in oil (w/o) nanoemulsion, depemding on the 
distribution of oil and aqueous phases. An oil-in-water 
nanoemulsion refers to a system having oil droplets 
dispersed in an aqueous phase. It is favorable delivery 
system for hydrophobic active substances whereas a water-
in-oil nanoemulsion is suitable for hydrophilic counterparts. 
Nanoemulsion is a promising tool for transdermal drug 
delivery and is defined as a dispersion consisting of oil, 
surfactant, cosurfactant, and aqueous phase, which is a single 
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optically isotropic and thermodynamically stable liquid 
solution with a droplet diameter usually in range of 10-200 
nm. Nanoemulsions also have attracted a great attention in 
delivery of therapeutically active agents since approximately 
40% of new chemical entities are hydrophobic in nature and 
the delivery of these poorly water soluble drugs is a 
challenge for delivery of drugs. In pharmaceutical field, 
nanoemulsions have been used as a drug delivery system 
through various systemic routes i.e. oral, topical and 
parenteral. Nanoemulgel which also known as the formation 
of nanoemulsion-based hydrogel is the addition of 
nanoemulsion system into hydrogel matrix.  In addition, with 
the gel based formulation of nanoemulgel, it exhibit 
upgraded properties of thixotropic, non-greasy, effortless 
spreadable, easily be removed, emollient, not staining, 
soluble in water, longer shelf life, bio-friendly, translucent 
and agreeable appearance. 1,2 
MATERIALS AND METHOD 
Materials 
Antifungal drug i.e. Tolnaftate gifted from Aarti Drugs Ltd. 
Mumbai, Carbopol 934, Tween 80, Propylene glycol, Almond 
Oil, Methyl Paraben, Propyl Paraben, BHT, was obtained 
from Research lab, Mumbai. Distilled water was used for all 
experiments. All chemicals were of pharmaceutical grade. 
Antifungal activity was performed on Trichophyton rubrum. 
Methodology 
High pressure homogenization methods are used for the 
formulation of nanoemulgel. There are three steps involved 
in the formulation of nanoemulgel which are given follows. 
1. Preparation of nanoemulsion 
2. Preparation of hydrogel and 
3. Finally nanoemulgel will be produced by the incorporation 
of Nanoemulsion into gel with continuous stirring. 
Formulation and development of nanoemulsion 
3 2 Full Factorial Design:  For the present work 32 full 
factorial designs was selected. It has been summarized in 
Table 01, In this design, 2 factors were evaluated each at 3 
levels and experimental trials were performed at all 9 
possible combinations as reflected in Table 01. The two 
independent variables selected were Almond oil (x1) and 
Speed of homogenizer (x2). 3 
 
Table 1: Composition of Nanoemulsion formulation as per 32 full factorial designs 
Formulation code F1 F2 F3 F4 F5 F6 F7 F8 F9 
Ingredients   %       
Tolnaftate  1 1 1 1 1 1 1 1 1 
Almond oil (v/v) 3 3 3 2 2 2 1 1 1 
Tween 80 (v/v) 5.25 5.25 5.25 5.25 5.25 5.25 5.25 5.25 5.25 
Propylene glycol (v/v) 1.75 1.75 1.75 1.75 1.75 1.75 1.75 1.75 1.75 
Methyl Paraben 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Propyl Paraben 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
BHT 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Water 100 100 100 100 100 100 100 100 100 
 
Method of preparation for nanoemulsion 
Preparation of aqueous phase ‘A’: Accurately weighed 
quantity of propylene glycol was added into distilled water 
(800c).  
 Preparation of Oil phase ‘B’: Weighed quantity of Almond 
oil and tween 80 mixed together by maintaining hot 
condition, simultaneously accurately weighed quantity of 
Tolnaftate was added into it then addition of methyl 
paraben, propyl paraben and BHT in it.  
Incorporation of solution ‘A’ in dispersion ‘B’: Both the 
phases were mixed properly with the help of High pressure 
Homogenizer maintaining the respective rpm. 4 
 Preparation of gel 
The weighed quantity of carbopol 934 was mixed in distilled 
water (4000c) further addition of triethanolamine to 
maintain the desired pH range of the solution. The 
uniformity in the stirring was maintained and then the gel 
was kept in the refrigerator for 24 hrs. 
Preparation of Emulgel 
Further incorporation of nanoemulsion containing 1% drug 
was incorporated to obtain emulgel. 
Evaluation of nanoemulsion  
 Scanning Electron Microscopy  
The morphology of nanoemulsion can be determined by 
scanning electron microscopy (SEM). SEM gives a three-
dimensional image of the partical. The samples are examined 
at suitable accelerating voltage, usually 20 kV, at different 
magnifications.   4 
 Particle Size Analysis  
Formulated Nanoemulsion should be analysed for their 
hydrodynamic particle size. Generally, in case of 
nanoemulsion dynamic light scattering method used for the 
measurement of particles and further particle size 
distribution. 4 
Zeta potential measurements     
Zeta potential for nanoemulsion was determined using 
zetasizer hsa 3000 (Malvern instrument Ltd., UK). Samples 
were placed in clear disposable zeta cells and results were 
recorded. Before putting the fresh sample, cuvettes were 
washed with the methanol and rinsed using the sample to be 
measured before each experiment. 5 
Evaluation of Nanoemulgel 
Physical Appearance 
The prepared nanoemulgel formulations were inspected 
visually for their colour, homogeneity, consistency and pH.  4 
 Determination of pH  
 pH of the formulation was determined by using digital pH 
meter. pH meter electrode was washed by distilled water 
and then dipped into formulation to measure pH and this 
process was repeated 3 times. 6, 7 
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Measurement of viscosity 
 The viscosity of the formulated batches was determined 
using a Brookfield Viscometer (RVDV-I Prime, Brookfield 
Engineering Laboratories, USA) with spindle 63. The 
formulation whose viscosity was to be determined was 
added to the beaker and was allowed to settle down for 30 
min at the assay temperature (25±1ºC) before. 6, 7 
 Drug content study  
 Drug content study was done to determine the amount of 
the drug present in the certain quantity of the formulation. 
Took 1 g of the formulation into 10 ml volumetric flask 
added methanol in it and shake well and make up the volume 
with methanol. The Volumetric flask was kept for 2 hr and 
shaken well in a shaker to mix it properly. The solution was 
passed through the filter paper and filtered the mixer then 
measured absorbance by using spectrophotometer at 257 
nm.  6, 7, 9 
 In-vitro Drug release study  
The in-vitro drug release studies of the Emulgel were carried 
out on Diffusion cell using egg membrane. This was clamped 
carefully to one end of the hollow glass tube of dialysis cell. 
Emulgel (1gm) was applied on to the surface of egg 
membrane dialysis membrane. The receptor chamber was 
filled with freshly prepared PBS (pH 7.4) solution. Total 
amount of gel filled in the tube to solubilize the drug. The 
receptor chamber was stirred by magnetic stirrer. The 
samples (1ml aliquots) were collected at suitable time 
interval sample were analyzed for drug content by UV visible 
spectrophotometer at 257 nm after appropriate dilutions. 6, 7, 
10 
Antifungal study  
An agar diffusion method used for determination the 
antifungal activity of formulation. Standard petri dish 9 cm 
containing medium to depth of 0.5 cm were used. The 
sterility of the lots was controlled before used. Incubation 
were prepared by suspending 1-2 colonies of Trichophyton 
rubrum (ATCC 28188) From 24 hr. Cultures in sabouraud’s 
medium in to tube contain 10 ml of sterile saline. The tubes 
were diluted with saline. The inoculum spread over the 
surface of agar medium. The plate The cumulative % drug 
release was calculated using standard calibration curve. was 
dried at 35º C for 15 min prior to placing the formulation. 
The boars of 0.5 cm diameter were prepaid and 20 μl sample 
of formulation (1 % w/v) were added in the bores. After 
incubation at 35ºC for 24 hr. the zone of inhibition around 
the boars are measure. 11 
Release kinetics of selected formulation  
To examine the drug release kinetics and mechanism, the 
cumulative release data were fitted to models representing 
Zero order (cumulative % drug release v/s. time), First order 
(log cumulative % drug retained v/s. time), Higuchi model 
(cumulative % drug retained v/s. Square root of time). 6, 7 
RESULT AND DISCUSSION 
Evaluation of Nanoemulsion 
Scanning Electron Microscopy 
Scanning electron microscopy of Nanoemulsion is shown in 
Fig. 01. The shape of Nanoemulsion was Spherical and the 
size of the Nanoemulsion was below micrometer range. 
Moreover, the micrograph also revealed the some 
agglomeration of nanoemulsion which might be due to the 
evaporation of water present in formulation during sample 
preparation prior to SEM analysis. 
 
Figure 1: Scanning Electron Microscopy 
 
Particle size and polydispersibility index 
 The Particle size of the Nanoemulsion of optimised batch 
was found to be 100 nm. It is seen with increase in 
concentration of Almond oil with high speed of homogenizer 
decrease in particle size. It is shown in Fig. 02. 
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Figure 2: Particle Size of Optimized Formulation 
 
Zeta Potential 
Zeta potential shows the stability of the (colloidal 
dispersion) nanoemulsion under the stress testing condition 
according to ICH guidelines of stability studies of various 
pharmaceutical formulations. Zeta potential is affected by 
particle size, lowest particle size in nano size i.e. 100, shows -
32 mV. Zeta potential which indicate thermodynamic 
instability of the dispersion. It is shows in Fig. 03. 
  
 
Figure 3: Zeta Potential of Optimized formulation 
 
Evaluation of Nanoemulgel 
 Physical Appearance 
The physical appearance of the emulgel formulation was 
found to be Translucent, homogeneous and consistent.  
 pH 
pH of various emulgel are shown in the table no 02 which 
was found to be in range of 6.31 to 6.84.  
Viscosity 
The viscosity values of formulations are shown in the Table 
03. 
Spreadability  
Spreadability shows the inverse relationship with the 
viscosity of the emulgel. Formulation F1, Having optimum 
viscosity and spreadability of this formulation is 17.77 
gm.cm/sec. spreadability shows in Table 04. 
Drug Content 
The drug content of formulation has shown in table no.05 
The percentage drug content of all prepared emulgel 
formulations was found to be in the range of 64 to 96%.  
 In-vitro drug release 
The in- vitro release of Tolnaftate from its various emulgel 
formula are represented in Table 06. 
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 Antifungal Activity 
Observed value of (% Drug suspension) for Tolnaftate 
against Trichophyton rubrum (ATCC 28188) for zone of 
inhibition is 15. The study indicates that Tolnaftate retained 
its antifungal activity when formulated in Nanoemulsion 
loaded emulgel and Tolnaftate was active against selected 
strain of micro-organism. F1 shows a zone of inhibition of 24 
mm. The results of antifungal activity of formulation have 
been shown in Table 07 Standard value of (Drug suspension) 
for Tolnaftate against Trichophyton rubrum for zone of 
inhibition is 24 mm.  
Table 2: pH values of formulation 
Sr. No. Formulation code Observed pH (± SD) 
1 F1 6.60±0.025 
2 F2 6.75±0.018 
3 F3 6.55±0.011 
4 F4 6.45±0.011 
5 F5 6.43±0.0158 
6 F6 6.33±0.011 
7 F7 6.31±0.005 
8 F8 6.40±0.018 
9 F9 6.53±0.026 
 
Table 3: Viscosity of formulations 
Rpm Viscosity (cP) at Room Temperature 
Formulation Code 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
10 14960 13450 14500 13750 12500 13500 14500 13500 12000 
20 14200 12390 14000 13400 12250 12440 14250 12500 11709 
30 13050 12050 13445 12350 11200 12203 13900 12000 10500 
40 13000 11500 12230 12010 11000 11253 12750 11500 9850 
50 12350 10420 11520 11250 10950 10504 12520 11200 9230 
 
Table 4:   Spreadability values of formulation 
Sr.no. Formulation code Spreadability (g.cm/sec)± S.D. 
1 F1 17.77 ± 0.025 
2 F2 16 ±0.035 
3 F3 15.38 ±0.028 
4 F4 15.68  ±0.018 
5 F5 15.09  ±0.032 
6 F6 14.81± 0.012 
7 F7 15.53± 0.012 
8 F8 15.23± 0.011 
9 F9 15.84  ±0.018 
 
Table 5: Drug content of formulation 
Sr. No. Formulation code Drug content (%)± SD 
1 F1 96±0.5 
2 F2 91.91±0.7 
3 F3 95±0.7 
4 F4 93.91±0.7 
5 F5 94±0.7 
6 F6 72±0.7 
7 F7 68±1.09 
8 F8 82±1.07 
9 F9 64.91±1.43 
 
Table 6: Cumulative amount of Tolnaftate diffused (%) from all the emulgel formulations through egg membrane using 
Modified Franz diffusion cell 
Time 
hrs 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
0 0 0 0 0 0 0 0 0 0 
1 9±0.70 8.17±0.76 7.14±0.22 6.25±0.071 6.13±0.75 5.34±0.82 5.01±0.70 3.41±0.85 2.31±0.53 
2 17±0.70 14.08±0.73 12.96±0.51 15.22±0.24 11.13±0.75 12.96±1.06 16.74±0.97 19.15±0.75 16.24±0.79 
3 25±1.07 24.21±0.74 23.01±0.16 22.11±0.17 23.12±0.74 19.66±0.39 21.30±0.81 18.12±0.74 20.11±0.74 
4 34±1.06 32.65±0.38 31.09±0.12 28.23±0.79 26.61±0.84 25.66±0.64 23.49±0.88 22.44±0.31 20.66±0.94 
5 41±0.70 40.42±0.85 40.97±0.52 35.49±0.88 30.99±0.50 32.67±0.95 34.69±095 39.45±0.69 39.41±0.85 
6 50±0.53 48.57±0.38 47.87±0.47 45.66±0.72 45.35±0.83 40.19±0.19 38.09±0.75 35.66±0.94 30.11±0.74 
7 59±1.06 57.45±0.31 55.13±0.94 52.79±0.99 48.49±0.88 44.09±0.10 41.49±0.88 38.09±0.73 37.71±0.96 
8 68±1.07 65.15±0.27 62.14±0.16 60.49±0.32 57.18±0.76 54.66±1.2 51.78±0.66 48.83±1 49.89±1.03 
12 78±1.41 72.30±0.28 74.25±0.32 64.49±0.33 62.16±0.75 58.19±0.19 56.99±1.07 54.97±1.04 52.31±0.81 
16 85±1.04 81.89±0.50 73.41±0.64 70.89±1.05 68.12±0.74 64.69±0.45 61.44±0.86 58.10±0.73 54.14±0.54 
24 96±0.66 90±0.38 87.42±0.30 78.94± 0.50 72.09±0.73 69.99±1.0 65.05±0.72 61.19±0.76 58.45±1.21 
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Table 7: Antifungal Activity of Formulation F1 to F9 
Sr.no. Formulation code Trichophyton rubrum 
Zone of inhibition (mm) 
1. F1 24 
2. F2 23 
3. F3 22 
4. F4 21 
5. F5 20 
6. F6 19 
7. F7 18.40 
8. F8 18 
9. F9 17 
10. 1% Drug suspension 15 
11. Marketed formulation (Tinactin cream 1%) 16.40 
12. 1% Formulated cream 15 
 
 
Drug release Kinetics 
In the present study, the drug release was analysed to study 
the kinetics of drug release mechanism. The results for zero 
order model kinetics and Higuchi model kinetics have shown 
in Fig. 4 and 5 respectively. 
 
Figure 4: Model graph for comparative evaluation of 
Zero order Kinetics 
 
 
Figure 5: Model graph for comparative evaluation of 
Higuchi Kinetics 
Comparative evaluation of Zero order kinetic model 
Zero order describes the system where the release rate of 
drug is independent of its concentration.  
 
 
 Comparative evaluation of Higuchi Kinetic model  
Higuchi developed model to study the release of water 
soluble and low soluble drugs incorporated in semisolid and 
solid matrices.  
CONCLUSION 
Finally it is concluded that the Nanoemulsion loaded emulgel 
of Tolnaftate can be one of the promising tool in controlling 
the drug release via. Percutaneous mechanism for effective 
and longer treatment required for fungal infections with 
increased stability.  
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